ofloxacin has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 3 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, H | 1 |
| Smith, AD | 1 |
| Kuo, PC | 1 |
| Vikraman, DS | 1 |
| Tsutsumi, M | 1 |
| Takada, A | 1 |
| Takase, S | 1 |
| Sawada, M | 1 |
| Bruguera, M | 1 |
1 review available for ofloxacin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
[Treatment of chronic hepatitis C: still many problems pending].
Topics: Adrenal Cortex Hormones; Aged; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiv | 1997 |
2 other studies available for ofloxacin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Streptococcus equi primary bacteremia in a hepatitis-C cirrhotic patient.
Topics: Anti-Bacterial Agents; Bacteremia; Hepatitis C; Humans; Liver Cirrhosis; Male; Middle Aged; Ofloxaci | 2009 |
Effects of combination therapy with interferon and ofloxacin on chronic type C hepatitis: a pilot study.
Topics: Adult; Anti-Infective Agents; Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Female; | 1996 |